Niels van de Donk

Research output

Research output per year 2012 2016 2018 2019 2020 2021 2022 2023 2024

• 113 Article
• 33 Review article
• 11 Letter
• 10 Meeting Abstract
• 11 More
  • 4 Comment/Letter to the editor
  • 3 Chapter
  • 2 Editorial
  • 1 Book
  • 1 Erratum/Corrigendum

Research output per year

Research output per year

Search results

• 2024

  GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review

  Rodriguez-Otero, P., van de Donk, N. W. C. J., Pillarisetti, K., Cornax, I., Vishwamitra, D., Gray, K., Hilder, B., Tolbert, J., Renaud, T., Masterson, T., Heuck, C., Kane, C., Verona, R., Moreau, P., Bahlis, N. & Chari, A., 1 Dec 2024, In: Blood Cancer Journal. 14, 1, 24.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access

• Monoclonal Antibodies in the Treatment of Multiple Myeloma

  van de Donk, N. W. C. J. & Zweegman, S., Apr 2024, In: Hematology/oncology clinics of North America. 38, 2, p. 337-360 24 p.

  Research output: Contribution to journal › Review article › Academic › peer-review
• 2023

  Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop

  Terpos, E., Neri, P., van de Donk, N. W. C. J., D'Agostino, M., Parekh, S., Jagannath, S., Ludwig, H., Avigan, D. E., Dhodapkar, M. V. & Raje, N. S., Jun 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 6, p. 413-419 7 p.

  Research output: Contribution to journal › Review article › Academic › peer-review
  2 Citations (Scopus)

• Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

  International Myeloma Working Group, 1 Jul 2023, In: The Lancet Oncology. 24, 7, p. e293-e311

  Research output: Contribution to journal › Review article › Academic › peer-review
  10 Citations (Scopus)

• Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma

  Moreau, P., van de Donk, N. W., Nahi, H., Oriol, A., Nooka, A. K., Martin, T., Rosinol, L., Karlin, L., Benboubker, L., Mateos, M-V., Popat, R., Martínez-López, J., Sidana, S., Delforge, M., Pei, L., Trancucci, D., Olyslager, Y., Uhlar, C., Stephenson, T., Rampelbergh, R. V., & 3 othersBanerjee, A., Kobos, R. & Usmani, S. Z., 1 Apr 2023, In: Future oncology (London, England). 19, 12, p. 811-818 8 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access

• Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma

  Chari, A., Askari, E., Caers, J., Costa, L. J., Hilder, B. W., Krishnan, A., Mateos, M-V., Minnema, M. C., Oriol, A., Pillarisetti, K., van de Donk, N. W. C. J. & Rodríguez-Otero, P., 1 Sept 2023, In: Future oncology (London, England). 19, 27, p. 1823-1840 18 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

  Ludwig, H., Terpos, E., van de Donk, N., Mateos, M-V., Moreau, P., Dimopoulos, M-A., Delforge, M., Rodriguez-Otero, P., San-Miguel, J., Yong, K., Gay, F., Einsele, H., Mina, R., Caers, J., Driessen, C., Musto, P., Zweegman, S., Engelhardt, M., Cook, G., Weisel, K., & 9 othersBroijl, A., Beksac, M., Bila, J., Schjesvold, F., Cavo, M., Hajek, R., Touzeau, C., Boccadoro, M. & Sonneveld, P., 1 Jun 2023, In: The Lancet Oncology. 24, 6, p. e255-e269

  Research output: Contribution to journal › Review article › Academic › peer-review
  18 Citations (Scopus)

• T-cell-engaging bispecific antibodies in cancer

  van de Donk, N. W. C. J. & Zweegman, S., 8 Jul 2023, In: The Lancet. 402, 10396, p. 142-158 17 p.

  Research output: Contribution to journal › Review article › Academic › peer-review
  25 Citations (Scopus)

• T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA

  van de Donk, N. W. C. J., O’Neill, C., de Ruijter, M. E. M., Verkleij, C. P. M. & Zweegman, S., 1 Nov 2023, In: Current opinion in oncology. 35, 6, p. 601-611 11 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
• 2021

  2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde

  Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., van de Donk, N., Terpos, E., Broijl, A., de Larrea, C. F., Gay, F., Goldschmidt, H., Hajek, R., Vangsted, A. J., Zamagni, E., Zweegman, S., Cavo, M., Dimopoulos, M., Einsele, H., Ludwig, H., Barosi, G., & 4 othersBoccadoro, M., Mateos, M. V., Sonneveld, P. & Miguel, J. S., Nov 2021, In: Haematologica. 106, 11, p. 2799-2812 14 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  21 Citations (Scopus)

• COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

  Ludwig, H., Sonneveld, P., Facon, T., San-Miguel, J., Avet-Loiseau, H., Mohty, M., Mateos, M. V., Moreau, P., Cavo, M., Pawlyn, C., Zweegman, S., Engelhardt, M., Driessen, C., Cook, G., Dimopoulos, M. A., Gay, F., Einsele, H., Delforge, M., Caers, J., Weisel, K., & 16 othersJackson, G., Garderet, L., van de Donk, N., Leleu, X., Goldschmidt, H., Beksac, M., Nijhof, I., Schreder, M., Abildgaard, N., Hajek, R., Zojer, N., Kastritis, E., Broijl, A., Schjesvold, F., Boccadoro, M. & Terpos, E., Dec 2021, In: The Lancet Haematology. 8, 12, p. e934-e946

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  40 Citations (Scopus)

• Current state of the art and prospects of t cell-redirecting bispecific antibodies in multiple myeloma

  Hosny, M., Verkleij, C. P. M., van der Schans, J., Frerichs, K. A., Mutis, T., Zweegman, S. & van de Donk, N. W. C. J., 1 Oct 2021, In: Journal of clinical medicine. 10, 19, 4593.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  9 Citations (Scopus)

• Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma

  van de Donk, N. W. C. J., Themeli, M. & Usmani, S. Z., 1 Jul 2021, In: Cancer discovery. 2, 4, p. 302-318 17 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access

• European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma

  Bruno, B., Wäsch, R., Engelhardt, M., Gay, F., Giaccone, L., D’Agostino, M., Rodríguez-Lobato, L-G., Danhof, S., Gagelmann, N., Kröger, N., Popat, R., van de Donk, N. W. C. J., Terpos, E., Dimopoulos, M. A., Sonneveld, P., Einsele, H. & Boccadoro, M., 1 Aug 2021, In: Haematologica. 106, 8, p. 2054-2065 12 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  22 Citations (Scopus)

• Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations

  Rosiñol, L., Beksac, M., Zamagni, E., Van de Donk, N. W. C. J., Anderson, K. C., Badros, A., Caers, J., Cavo, M., Dimopoulos, M. A., Dispenzieri, A., Einsele, H., Engelhardt, M., Fernández de Larrea, C., Gahrton, G., Gay, F., Hájek, R., Hungria, V., Jurczyszyn, A., Kröger, N., Kyle, R. A., & 18 othersLeal da Costa, F., Leleu, X., Lentzsch, S., Mateos, M. V., Merlini, G., Mohty, M., Moreau, P., Rasche, L., Reece, D., Sezer, O., Sonneveld, P., Usmani, S. Z., Vanderkerken, K., Vesole, D. H., Waage, A., Zweegman, S., Richardson, P. G. & Bladé, J., Aug 2021, In: British journal of haematology. 194, 3, p. 496-507 12 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  58 Citations (Scopus)

• Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

  Ludwig, H., Boccadoro, M., Moreau, P., San-Miguel, J., Cavo, M., Pawlyn, C., Zweegman, S., Facon, T., Driessen, C., Hajek, R., Dimopoulos, M. A., Gay, F., Avet-Loiseau, H., Terpos, E., Zojer, N., Mohty, M., Mateos, M. V., Einsele, H., Delforge, M., Caers, J., & 12 othersWeisel, K., Jackson, G., Garderet, L., Engelhardt, M., van de Donk, N., Leleu, X., Goldschmidt, H., Beksac, M., Nijhof, I., Abildgaard, N., Bringhen, S. & Sonneveld, P., Jan 2021, In: Leukemia. 35, 1, p. 31-44 14 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  77 Citations (Scopus)

• Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

  Moreau, P., Kumar, S. K., San Miguel, J., Davies, F., Zamagni, E., Bahlis, N., Ludwig, H., Mikhael, J., Terpos, E., Schjesvold, F., Martin, T., Yong, K., Durie, B. G. M., Facon, T., Jurczyszyn, A., Sidana, S., Raje, N., van de Donk, N., Lonial, S., Cavo, M., & 50 othersKristinsson, S. Y., Lentzsch, S., Hajek, R., Anderson, K. C., João, C., Einsele, H., Sonneveld, P., Engelhardt, M., Fonseca, R., Vangsted, A., Weisel, K., Baz, R., Hungria, V., Berdeja, J. G., Leal da Costa, F., Maiolino, A., Waage, A., Vesole, D. H., Ocio, E. M., Quach, H., Driessen, C., Bladé, J., Leleu, X., Riva, E., Bergsagel, P. L., Hou, J., Chng, W. J., Mellqvist, U. H., Dytfeld, D., Harousseau, J. L., Goldschmidt, H., Laubach, J., Munshi, N. C., Gay, F., Beksac, M., Costa, L. J., Kaiser, M., Hari, P., Boccadoro, M., Usmani, S. Z., Zweegman, S., Holstein, S., Sezer, O., Harrison, S., Nahi, H., Cook, G., Mateos, M. V., Rajkumar, S. V., Dimopoulos, M. A. & Richardson, P. G., Mar 2021, In: The Lancet Oncology. 22, 3, p. e105-e118

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  137 Citations (Scopus)
• 2020

  Dual Targeting to Overcome Current Challenges in Multiple Myeloma CAR T-Cell Treatment

  van der Schans, J. J., van de Donk, N. W. C. J. & Mutis, T., 5 Aug 2020, In: Frontiers in Oncology. 10, 1362.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  44 Citations (Scopus)

• Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

  Terpos, E., Engelhardt, M., Cook, G., Gay, F., Mateos, M. V., Ntanasis-Stathopoulos, I., van de Donk, N. W. C. J., Avet-Loiseau, H., Hajek, R., Vangsted, A. J., Ludwig, H., Zweegman, S., Moreau, P., Einsele, H., Boccadoro, M., San Miguel, J., Dimopoulos, M. A. & Sonneveld, P., 1 Aug 2020, In: Leukemia. 34, 8, p. 2000-2011 12 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  103 Citations (Scopus)

• Targeted Therapy With Immunoconjugates for Multiple Myeloma

  Bruins, W. S. C., Zweegman, S., Mutis, T. & van de Donk, N. W. C. J., 19 Jun 2020, In: Frontiers in immunology. 11, p. 1155 1155.

  Research output: Contribution to journal › Review article › Academic › peer-review
  37 Citations (Scopus)

• T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma

  Verkleij, C. P. M., Frerichs, K. A., Broekmans, M., Absalah, S., Maas-Bosman, P. W. C., Kruyswijk, S., Nijhof, I. S., Mutis, T., Zweegman, S. & van de Donk, N. W. C. J., 10 Nov 2020, In: Oncotarget. 11, 45, p. 4076-4081 6 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  21 Citations (Scopus)
• 2019

  Carfilzomib for relapsed and refractory multiple myeloma

  Groen, K., van de Donk, N., Stege, C., Zweegman, S. & Nijhof, I. S., 2019, In: Cancer management and research. 11, p. 2663-2675 13 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  48 Citations (Scopus)

• Immunotherapy in myeloma: how far have we come?

  Franssen, L. E., Mutis, T., Lokhorst, H. M. & van de Donk, N. W. C. J., 2019, In: Therapeutic advances in hematology. 10, p. 2040620718822660

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access

• Insights on Multiple Myeloma Treatment Strategies

  Mateos, M. V., Ludwig, H., Bazarbachi, A., Beksac, M., Bladé, J., Boccadoro, M., Cavo, M., Delforge, M., Dimopoulos, M. A., Facon, T., Geraldes, C., Goldschmidt, H., Hájek, R., Hansson, M., Jamroziak, K., Leiba, M., Masszi, T., Mendeleeva, L., O'Dwyer, M., Plesner, T., & 7 othersSan-Miguel, J. F., Straka, C., Van De Donk, N. W. C. J., Yong, K., Zver, S., Moreau, P. & Sonneveld, P., 1 Feb 2019, In: HemaSphere. 3, 1, e163.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  31 Citations (Scopus)

• International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

  Hillengass, J., Usmani, S., Rajkumar, S. V., Durie, B. G. M., Mateos, M-V., Lonial, S., Joao, C., Anderson, K. C., García-Sanz, R., Serra, E. R., du, J., van de Donk, N., Berdeja, J. G., Terpos, E., Zamagni, E., Kyle, R. A., San Miguel, J., Goldschmidt, H., Giralt, S., Kumar, S., & 15 othersRaje, N., Ludwig, H., Ocio, E., Schots, R., Einsele, H., Schjesvold, F., Chen, W-M., Abildgaard, N., Lipe, B. C., Dytfeld, D., Wirk, B. M., Drake, M., Cavo, M., Lahuerta, J. J. & Lentzsch, S., 1 Jun 2019, In: The Lancet Oncology. 20, 6, p. e302-e312

  Research output: Contribution to journal › Review article › Academic › peer-review
  281 Citations (Scopus)

• Reprint of “Immunomodulatory effects of CD38-targeting antibodies”

  van de Donk, N. W. C. J., Jan 2019, In: Immunology letters. 205, p. 71-77 7 p.

  Research output: Contribution to journal › Review article › Academic › peer-review
  13 Citations (Scopus)
• 2018

  CD38 antibodies in multiple myeloma: Back to the future

  van de Donk, N. W. C. J., Richardson, P. G. & Malavasi, F., 2018, In: Blood. 131, 1, p. 13-29

  Research output: Contribution to journal › Review article › Academic › peer-review
  315 Citations (Scopus)

• CD38 antibodies in multiple myeloma: Mechanisms of action and modes of resistance

  van de Donk, N. W. C. J. & Usmani, S. Z., 2018, In: Frontiers in immunology. 9, SEP, 2134.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  198 Citations (Scopus)

• European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

  Gavriatopoulou, M., Musto, P., Caers, J., Merlini, G., Kastritis, E., van de Donk, N., Gay, F., Hegenbart, U., Hajek, R., Zweegman, S., Bruno, B., Straka, C., Dimopoulos, M. A., Einsele, H., Boccadoro, M., Sonneveld, P., Engelhardt, M. & Terpos, E., 2018, In: Leukemia. 32, 9, p. 1883-1898

  Research output: Contribution to journal › Review article › Academic › peer-review
  74 Citations (Scopus)

• From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

  Gay, F., Engelhardt, M., Terpos, E., Wäsch, R., Giaccone, L., Auner, H. W., Caers, J., Gramatzki, M., van de Donk, N., Oliva, S., Zamagni, E., Garderet, L., Straka, C., Hajek, R., Ludwig, H., Einsele, H., Dimopoulos, M., Boccadoro, M., Kröger, N., Cavo, M., & 3 othersGoldschmidt, H., Bruno, B. & Sonneveld, P., Feb 2018, In: Haematologica. 103, 2, p. 197-211 15 p.

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  102 Citations (Scopus)

• Immunomodulatory effects of CD38-targeting antibodies

  van de Donk, N. W. C. J., 2018, In: Immunology letters. 199, p. 16-22

  Research output: Contribution to journal › Review article › Academic › peer-review
  67 Citations (Scopus)

• Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network

  Ludwig, H., Delforge, M., Facon, T., Einsele, H., Gay, F., Moreau, P., Avet-Loiseau, H., Boccadoro, M., Hajek, R., Mohty, M., Cavo, M., Dimopoulos, M. A., San-Miguel, J. F., Terpos, E., Zweegman, S., Garderet, L., Mateos, M-V., Cook, G., Leleu, X., Goldschmidt, H., & 12 othersJackson, G., Kaiser, M., Weisel, K., van de Donk, N. W. C. J., Waage, A., Beksac, M., Mellqvist, U. H., Engelhardt, M., Caers, J., Driessen, C., Bladé, J. & Sonneveld, P., 2018, In: Leukemia. 32, 7, p. 1542-1560

  Research output: Contribution to journal › Review article › Academic › peer-review
  66 Citations (Scopus)
• 2012

  Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma

  Van De Donk, N. W. C. J., Kamps, S., Mutis, T. & Lokhorst, H. M., 1 Feb 2012, In: Leukemia. 26, 2, p. 199-213 15 p.

  Research output: Contribution to journal › Review article › Academic › peer-review
  67 Citations (Scopus)